Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Metagenomic investigation of microbes and viruses in patients with jaw osteonecrosis associated with bisphosphonate therapy.

Sedghizadeh PP, Yooseph S, Fadrosh DW, Zeigler-Allen L, Thiagarajan M, Salek H, Farahnik F, Williamson SJ.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Dec;114(6):764-70. doi: 10.1016/j.oooo.2012.08.444.

2.

Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw.

Pushalkar S, Li X, Kurago Z, Ramanathapuram LV, Matsumura S, Fleisher KE, Glickman R, Yan W, Li Y, Saxena D.

Int J Oral Sci. 2014 Dec;6(4):219-26. doi: 10.1038/ijos.2014.46. Epub 2014 Aug 8.

3.

Molecular profiling of oral microbiota in jawbone samples of bisphosphonate-related osteonecrosis of the jaw.

Wei X, Pushalkar S, Estilo C, Wong C, Farooki A, Fornier M, Bohle G, Huryn J, Li Y, Doty S, Saxena D.

Oral Dis. 2012 Sep;18(6):602-12. doi: 10.1111/j.1601-0825.2012.01916.x. Epub 2012 Mar 23.

PMID:
22443347
4.

Antibiotic effects on bacterial profile in osteonecrosis of the jaw.

Ji X, Pushalkar S, Li Y, Glickman R, Fleisher K, Saxena D.

Oral Dis. 2012 Jan;18(1):85-95. doi: 10.1111/j.1601-0825.2011.01848.x. Epub 2011 Aug 29.

5.

Electrically conductive bacterial nanowires in bisphosphonate-related osteonecrosis of the jaw biofilms.

Wanger G, Gorby Y, El-Naggar MY, Yuzvinsky TD, Schaudinn C, Gorur A, Sedghizadeh PP.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jan;115(1):71-8. doi: 10.1016/j.oooo.2012.08.446.

PMID:
23217537
6.

Salivary proteomics in bisphosphonate-related osteonecrosis of the jaw.

Thumbigere-Math V, Michalowicz BS, de Jong EP, Griffin TJ, Basi DL, Hughes PJ, Tsai ML, Swenson KK, Rockwell L, Gopalakrishnan R.

Oral Dis. 2015 Jan;21(1):46-56. doi: 10.1111/odi.12204. Epub 2013 Nov 29.

7.

Microbiological investigation of medication-related osteonecrosis of the jaw: preliminary results.

Crincoli V, Ballini A, Di Comite M, Tettamanti L, Coscia MF, Mastrangelo F, De Vito D.

J Biol Regul Homeost Agents. 2015 Oct-Dec;29(4):977-83.

PMID:
26753664
8.

Important aspects regarding the role of microorganisms in bisphosphonate-related osteonecrosis of the jaws.

Boff RC, Salum FG, Figueiredo MA, Cherubini K.

Arch Oral Biol. 2014 Aug;59(8):790-9. doi: 10.1016/j.archoralbio.2014.05.002. Epub 2014 May 10. Review.

PMID:
24859766
9.

Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ).

Rollason V, Laverrière A, MacDonald LC, Walsh T, Tramèr MR, Vogt-Ferrier NB.

Cochrane Database Syst Rev. 2016 Feb 26;2:CD008455. doi: 10.1002/14651858.CD008455.pub2. Review.

PMID:
26919630
10.

[Conditionally pathogenic microorganisms in patients with bisphosphonate jaw osteonecrosis].

Ivanyushko TP, Polyakov KA, Medvedev YA, Shamanaev SV, Trofimov DY, Abramov DD, Balyikin RA.

Stomatologiia (Mosk). 2016;95(1):44-8. Russian.

PMID:
26925566
11.

Interleukin-6 concentration changes in plasma and saliva in bisphosphonate-related osteonecrosis of the jaws.

Bagan J, Sáez GT, Tormos MC, Hens E, Terol MJ, Bagan L, Diaz-Fernández JM, Lluch A, Camps C.

Oral Dis. 2014 Jul;20(5):446-52. doi: 10.1111/odi.12150. Epub 2013 Jul 10.

PMID:
23837828
12.

Genetic investigation of bisphosphonate-related osteonecrosis of jaw (BRONJ) via whole exome sequencing and bioinformatics.

Kim JH, Ko YJ, Kim JY, Oh Y, Hwang J, Han S, Kim S, Lee JH, Han DH.

PLoS One. 2015 Feb 10;10(2):e0118084. doi: 10.1371/journal.pone.0118084. eCollection 2015.

13.

Histomorphologic characteristics of bisphosphonate-related osteonecrosis of the jaw.

Koerdt S, Dax S, Grimaldi H, Ristow O, Kuebler AC, Reuther T.

J Oral Pathol Med. 2014 Jul;43(6):448-53. doi: 10.1111/jop.12156. Epub 2014 Jan 23.

PMID:
24456519
14.

Epidemiology, pharmacology and clinical characterization of bisphosphonate-related osteonecrosis of the jaw. A retrospective study of 70 cases.

Pelaz A, Junquera L, Gallego L, García-Consuegra L, García-Martínez L, Cutilli T, Olay S.

Acta Otorrinolaringol Esp. 2015 May-Jun;66(3):139-47. doi: 10.1016/j.otorri.2014.06.003. Epub 2014 Oct 11. English, Spanish.

15.

Characteristics of the early stages of intravenous bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.

Matsuo A, Hamada H, Kaise H, Chikazu D, Yamada K, Kohno N.

Acta Odontol Scand. 2014 Nov;72(8):656-63. doi: 10.3109/00016357.2014.887772. Epub 2014 Feb 12.

PMID:
24521290
16.

Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.

Assaf AT, Smeets R, Riecke B, Weise E, Gröbe A, Blessmann M, Steiner T, Wikner J, Friedrich RE, Heiland M, Hoelzle F, Gerhards F.

Anticancer Res. 2013 Sep;33(9):3917-24.

PMID:
24023329
17.

Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): the missing link?

De Ceulaer J, Tacconelli E, Vandecasteele SJ.

Eur J Clin Microbiol Infect Dis. 2014 Nov;33(11):1873-80. doi: 10.1007/s10096-014-2160-5. Epub 2014 Jun 1. Review.

PMID:
24880820
18.

Analysis of the factors affecting the formation of the microbiome associated with chronic osteomyelitis of the jaw.

Goda A, Maruyama F, Michi Y, Nakagawa I, Harada K.

Clin Microbiol Infect. 2014 May;20(5):O309-17. doi: 10.1111/1469-0691.12400. Epub 2013 Nov 11.

19.

Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction.

Bodem JP, Kargus S, Eckstein S, Saure D, Engel M, Hoffmann J, Freudlsperger C.

J Craniomaxillofac Surg. 2015 May;43(4):510-4. doi: 10.1016/j.jcms.2015.02.018. Epub 2015 Mar 9.

PMID:
25841311
20.

Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.

O'Ryan FS, Lo JC.

J Oral Maxillofac Surg. 2012 Aug;70(8):1844-53. doi: 10.1016/j.joms.2011.08.033. Epub 2012 May 16.

PMID:
22595135

Supplemental Content

Support Center